Created at Source Raw Value Validated value
May 25, 2021, 12:32 a.m. usa

[{"arm_notes": "nan", "treatment_id": null, "treatment_name": "AZD7442 1000 mg IV (male);AZD7442 300 mg IM(male);AZD7442 300 mg IV (male and female);AZD7442 600 mg IM (male)", "treatment_type": "Biological;Biological;Biological;Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "AZD7442 1000 mg IV (male);AZD7442 300 mg IM(male);AZD7442 300 mg IV (male and female);AZD7442 600 mg IM (male)", "treatment_type": "Biological;Biological;Biological;Biological", "pharmacological_treatment": "Non pharmacological treatment"}]

[{"arm_notes": "300 mg IM (male)", "treatment_id": 1465, "treatment_name": "Cilgavimab+tixagevimab", "treatment_type": "Monoclonal antibodies", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "300 mg IV (male and female)", "treatment_id": 1465, "treatment_name": "Cilgavimab+tixagevimab", "treatment_type": "Monoclonal antibodies", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "600 mg IM (male)", "treatment_id": 1465, "treatment_name": "Cilgavimab+tixagevimab", "treatment_type": "Monoclonal antibodies", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "1000 mg IV (male)", "treatment_id": 1465, "treatment_name": "Cilgavimab+tixagevimab", "treatment_type": "Monoclonal antibodies", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]